AMGN
Amgen Inc.
- Shareholders' equity, 2025
- $8.7B
- YoY, 2025
- +47.3%
- 5-year CAGR
- −1.6%
- 10-year CAGR
- −11.1%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $8.7B | +47.3% |
| 2024 | $5.9B | −5.7% |
| 2023 | $6.2B | +70.2% |
| 2022 | $3.7B | −45.4% |
| 2021 | $6.7B | −28.8% |
| 2020 | $9.4B | −2.7% |
| 2019 | $9.7B | −22.6% |
| 2018 | $12.5B | −50.5% |
| 2017 | $25.2B | −15.5% |
| 2016 | $29.9B | +6.4% |
| 2015 | $28.1B | +8.9% |
| 2014 | $25.8B | +16.7% |
| 2013 | $22.1B | +15.9% |
| 2012 | $19.1B | +0.2% |
| 2011 | $19.0B | −20.5% |
| 2010 | $23.9B | +5.6% |
| 2009 | $22.7B | +8.5% |
| 2008 | $20.9B | +12.8% |
| 2007 | $18.5B | — |